JPWO2022046809A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022046809A5 JPWO2022046809A5 JP2023513299A JP2023513299A JPWO2022046809A5 JP WO2022046809 A5 JPWO2022046809 A5 JP WO2022046809A5 JP 2023513299 A JP2023513299 A JP 2023513299A JP 2023513299 A JP2023513299 A JP 2023513299A JP WO2022046809 A5 JPWO2022046809 A5 JP WO2022046809A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- feline
- fusion protein
- raav vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282324 Felis Species 0.000 claims 15
- 239000013608 rAAV vector Substances 0.000 claims 13
- 108020001507 fusion proteins Proteins 0.000 claims 11
- 102000037865 fusion proteins Human genes 0.000 claims 11
- 150000001413 amino acids Chemical group 0.000 claims 6
- 238000006467 substitution reaction Methods 0.000 claims 6
- 229940089838 Glucagon-like peptide 1 receptor agonist Drugs 0.000 claims 5
- 108090000190 Thrombin Proteins 0.000 claims 5
- 229960004072 thrombin Drugs 0.000 claims 5
- 241000702421 Dependoparvovirus Species 0.000 claims 4
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
- 239000003877 glucagon like peptide 1 receptor agonist Substances 0.000 claims 4
- 101800004266 Glucagon-like peptide 1(7-37) Proteins 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 3
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 229920001184 polypeptide Polymers 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 239000013598 vector Substances 0.000 claims 3
- 102000009027 Albumins Human genes 0.000 claims 2
- 108010088751 Albumins Proteins 0.000 claims 2
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims 2
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims 2
- 102400000324 Glucagon-like peptide 1(7-37) Human genes 0.000 claims 2
- 210000000234 capsid Anatomy 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 1
- 241000958487 Adeno-associated virus 3B Species 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 230000037396 body weight Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063069492P | 2020-08-24 | 2020-08-24 | |
| US63/069,492 | 2020-08-24 | ||
| PCT/US2021/047403 WO2022046809A1 (en) | 2020-08-24 | 2021-08-24 | Viral vector encoding glp-1 receptor agonist fusions and uses thereof in treating metabolic diseases in felines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539247A JP2023539247A (ja) | 2023-09-13 |
| JPWO2022046809A5 true JPWO2022046809A5 (https=) | 2024-09-02 |
| JP2023539247A5 JP2023539247A5 (https=) | 2024-09-02 |
Family
ID=80355670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513299A Pending JP2023539247A (ja) | 2020-08-24 | 2021-08-24 | Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230405150A1 (https=) |
| EP (1) | EP4199942A4 (https=) |
| JP (1) | JP2023539247A (https=) |
| KR (1) | KR20230054419A (https=) |
| CN (1) | CN116390745A (https=) |
| AU (1) | AU2021332232A1 (https=) |
| CA (1) | CA3190396A1 (https=) |
| WO (1) | WO2022046809A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026039359A1 (en) | 2024-08-12 | 2026-02-19 | Akston Biosciences Corporation | Fc fusion protein therapeutics for companion animal obesity and methods of use |
| WO2026039340A1 (en) | 2024-08-12 | 2026-02-19 | Akston Biosciences Corporation | Fc fusion protein therapeutics for companion animal obesity and methods of use |
| WO2026039341A1 (en) | 2024-08-12 | 2026-02-19 | Akston Biosciences Corporation | Fc fusion protein therapeutics for companion animal obesity and methods of use |
| CN120005002B (zh) * | 2025-04-22 | 2025-07-25 | 西宝生物科技(上海)股份有限公司 | 一种glp-1类似物的生物发酵制备方法及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0116024A (pt) * | 2000-12-07 | 2005-12-13 | Lilly Co Eli | Proteìna de fusão heteróloga e uso da mesma |
| CA2833623A1 (en) * | 2011-04-20 | 2012-10-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity |
| EP3332012A4 (en) * | 2015-08-06 | 2019-01-16 | The Trustees of The University of Pennsylvania | GLP-1 AND USE THEREOF IN COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISEASES |
| CN110267674A (zh) * | 2016-07-08 | 2019-09-20 | 奥美药业有限公司 | 包含瘦素的融合蛋白及其生产和使用方法 |
| BR112020002871A2 (pt) * | 2017-08-15 | 2020-07-28 | Kindred Biosciences, Inc. | variantes fc de igg para uso veterinário |
| MX2021007680A (es) * | 2018-12-27 | 2021-10-13 | Kindred Biosciences Inc | Variantes de igg fc para uso veterinario. |
-
2021
- 2021-08-24 EP EP21862600.0A patent/EP4199942A4/en active Pending
- 2021-08-24 US US18/042,729 patent/US20230405150A1/en active Pending
- 2021-08-24 CN CN202180072448.2A patent/CN116390745A/zh active Pending
- 2021-08-24 CA CA3190396A patent/CA3190396A1/en active Pending
- 2021-08-24 WO PCT/US2021/047403 patent/WO2022046809A1/en not_active Ceased
- 2021-08-24 JP JP2023513299A patent/JP2023539247A/ja active Pending
- 2021-08-24 KR KR1020237009389A patent/KR20230054419A/ko active Pending
- 2021-08-24 AU AU2021332232A patent/AU2021332232A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7654562B2 (ja) | 線維芽細胞増殖因子23関連低リン血症性疾患の遺伝子療法 | |
| JP2020510428A5 (https=) | ||
| CN111954537A (zh) | 生长分化因子15融合蛋白 | |
| WO2006102072A2 (en) | Use of a pa131 polypeptide in treatment of atherosclerosis | |
| JP2023539247A (ja) | Glp-1受容体アゴニスト融合物をコードするウイルスベクター及びネコの代謝性疾患の治療におけるその使用 | |
| JP7840319B2 (ja) | Glp-1受容体アゴニスト融合物をコードするウイルスベクター及び代謝性疾患の治療におけるその使用 | |
| JPWO2021102107A5 (https=) | ||
| JPWO2022046809A5 (https=) | ||
| US20250171515A1 (en) | Aav vectors for delivery of glp-1 receptor agonist fusions | |
| JP2021521782A5 (https=) | ||
| WO2023045996A1 (zh) | 一种用于糖代谢相关疾病基因治疗的核酸构建体 | |
| JPWO2020167996A5 (https=) | ||
| JPWO2020047467A5 (https=) | ||
| CN119522285A (zh) | 编码glp-2受体激动剂融合物的病毒载体及其在治疗短肠综合征中的用途 | |
| JPWO2020237130A5 (https=) | ||
| JPWO2022015418A5 (https=) | ||
| JPWO2019204303A5 (https=) | ||
| WO2026035486A2 (en) | G protein-coupled receptor (gpcr) agonists and use thereof | |
| HK40091844A (zh) | 双功能蛋白质和包含其的药物组合物 | |
| HK40086042A (zh) | 双功能蛋白质和包含其的药物组合物 | |
| JPWO2022165421A5 (https=) | ||
| CA3215384A1 (en) | Methods and means for the prevention and/or treatment of hemophilic arthropathy in hemophilia | |
| JPWO2023168411A5 (https=) | ||
| JPWO2022006551A5 (https=) | ||
| RU2021123108A (ru) | Генотерапевтические конструкции для лечения болезни вильсона |